AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financing is intended to redeem bonds totaling €50.4 million that mature in 2026. Tallinna Sadam operates one of the largest cargo and passenger port complexes in the Baltic Sea and has subsidiaries in ferry services and icebreaking operations. This refinancing extends the company's debt maturity and supports its ongoing operations and investments.
The story on AS Tallinna Sadam's debt changes offers context for readers following Industrials-sector stocks. For readers following Industrials, here is Pluang's market snapshot as of Oct 26, 2026 20:01 WIB: out of 135 priced stocks, 78 rose and 24 fell. Notable movers include GFL at USD 44.29 with a -2.79% change and a typical hold time of 17 days, Frontline at USD 54.12 with a +2.22% change, and Vertiv at USD 198.43 with a +2.12% change and a typical hold time of 43 days.
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
Neo Security has named Scott Stout as its new Chief Revenue Officer to lead global revenue growth and expand sales of its agentic software security platform. Stout brings over 20 years of cybersecurity experience, including leadership roles at Cisco ...
ThredUp's 2026 Holiday Resale Report reveals that 62% of Americans intend to buy secondhand gifts this holiday season, with 55% preferring unique, vintage items over brand-new ones. Shoppers are allocating about 37% of their gift budget to secondhand...
Senseonics Holdings has begun the first human clinical trial of Freedom, a next-generation continuous glucose monitoring (CGM) system designed without an external on-body transmitter. This implantable device communicates directly with mobile devices ...
